Role of the primary care professional in the care of the patient with prostate cancer: a UK perspective There is an increase in the use of prognostic gene expression biomarkers in the USA for the personalisation of treatment for men with localised and recurre... M Kirby - 《Treatment Methods...
↵ Donovan J , Frankel S , Neal D , Hamdy F . Screening for prostate cancer in the UK. BMJ 2001 ; 323 : 763 – 764 .Donovan JL, Frankel SJ, Neal DE, Hamdy FC. Screening for prostate cancer in the UK. BMJ 2001;323:763-4....
after more than 3 decades of widespread PSA screening to detect prostate cancer, there are few men with high PSA levels that haven’t already been diagnosed. Second, and perhaps more important, PSA screening is now becoming less common. In 2008, the US Preventive Services Task Force (USPSTF)...
Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 2006;98(4):777-782.PubMedGoogle ScholarCrossref 35. Katz DA, Jarrard DF, McHorney CA, Hillis SL, Wiebe DA, Fryback DG. Health perceptions in patients who ...
This study aimed to explore the opinions of healthcare professionals regarding the management of men with advanced prostate cancer with particular emphasis on treatment timing and sequencing; treatment adverse-effects and exercise a supportive therapy. Semi-structured interviews with a purposively selected...
Dr Chris Metcalfe, Lecturer in Medical Statistics and collaborator on the project, said: “This is the first evidence from the UK on differences between Black and White men in rates of prostate cancer. “ He added: “There are very few known risk factors for prostate cancer but as we exclu...
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and management differ around the world. To identify the highest priority research
Prostate cancer Qualitative 1. Introduction Prostate canceris the most common cancer in men in the UK (Cancer Research UK) and the number ofprostate cancer diagnosesis set to increase in the future largely due to improvements in detection (Maddams et al., 2012). Over the last ten years the...
Prostate cancer is the most common male cancer in the UK—one in eight men will get it in their lifetime. Preventing relapse Professor Norman Maitland, from the Department of Biology at the University of York, said: "The strong response we observed was due to the powerful cellular function ...
Prostate Cancer UK has a simple ambition - to stop men dying from prostate cancer. Through shifting the science over the next 10 years to focus on radical improvements in diagnosis, treatment, prevention, and support, we will stop prostate cancer being a killer. Find out more about fundraising...